NeoGenomics and Needham & Company

Selected Headlines

Date Headline (link) Source Relevant Snippet
8/27/2021 NeoGenomics (NASDAQ:NEO) Price Target Increased to $50.00 by Analysts at Benchmark NeoGenomics (NASDAQ:NEO) had its price target boosted by Benchmark from $46.00 to $50.00 in a research report sent to investors on Thursday, The Fly reports. The brokerage currently has a buy rating on the ... rating in a research note on Tuesday, August 17th. Finally, Needham & Company LLC reiterated a buy rating and set a $55.00 price target on shares of NeoGenomics in a report on Monday, August 9th. Two ...
8/27/2021 NeoGenomics (NASDAQ:NEO) Price Target Raised to $50.00 NeoGenomics (NASDAQ:NEO) had its price objective raised by Benchmark from $46.00 to $50.00 in a research report report published on Thursday, The Fly reports. The brokerage currently has a buy rating on the medical ... hold rating in a research report on Tuesday, August 17th. Needham & Company LLC reiterated a buy rating and set a $55.00 price target on shares of NeoGenomics in a research report on Monday, August 9th ...
8/27/2021 Investment Analysts‚Äô Recent Ratings Changes for NeoGenomics (NEO) Mayfield Recorder Several analysts have recently updated their ratings and price targets for NeoGenomics (NASDAQ: NEO): - 8/26/2021 ‚Ai NeoGenomics had its price target raised by analysts at Benchmark Co. from $46.00 to $50.00. They now have a ... NeoGenomics had its ‚Aubuy‚Au rating reaffirmed by analysts at Needham & Company LLC. They now have a $55.00 price target on the stock. - 7/13/2021 ‚Ai NeoGenomics is now covered by analysts at Needham & Company LLC ...
8/27/2021 Investment Analysts‚Äô Recent Ratings Changes for NeoGenomics (NEO) Several analysts have recently updated their ratings and price targets for NeoGenomics (NASDAQ: NEO): - 8/26/2021 ‚Ai NeoGenomics had its price target raised by analysts at Benchmark Co. from $46.00 to $50.00. They now have a ... NeoGenomics had its ‚Aubuy‚Au rating reaffirmed by analysts at Needham & Company LLC. They now have a $55.00 price target on the stock. - 7/13/2021 ‚Ai NeoGenomics is now covered by analysts at Needham & Company LLC ...
8/26/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of ‚ÄúBuy‚Äù from Analysts - Transcript Daily NeoGenomics, Inc. (NASDAQ:NEO) has received a consensus rating of ‚AuBuy‚Au from the twelve brokerages that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating ... NEO has been the topic of several recent analyst reports. Needham & Company LLC reaffirmed a ‚Aubuy‚Au rating and set a $55.00 target price on shares of NeoGenomics in a research report on Monday, August ...
8/26/2021 Benchmark Boosts NeoGenomics (NASDAQ:NEO) Price Target to $50.00 - Watch List News NeoGenomics (NASDAQ:NEO) had its price objective upped by equities researchers at Benchmark from $46.00 to $50.00 in a note issued to investors on Thursday, The Fly reports. The firm currently has a ‚Aubuy‚Au ... the stock in a research note on Monday, August 9th. Needham & Company LLC reaffirmed a ‚Aubuy‚Au rating and set a $55.00 target price on shares of NeoGenomics in a research note on Monday, August ...
8/25/2021 EveryCoin 24 Hour Volume Hits $151,368.00 (EVY) | Daily Political Daily Political NeoGenomics, Inc. (NASDAQ:NEO) Expected to Announce Quarterly Sales of $128.12 Million Posted by Stacy Sanders on Aug 24th, 2021 Share on StocktwitsEquities analysts predict that NeoGenomics, Inc. (NASDAQ:NEO) will report $128.12 million ... number of equities analysts have weighed in on the company. Needham & Company LLC restated a ‚Aubuy‚Au rating and issued a $55.00 target price on shares of NeoGenomics in a research note on Monday, August ...
8/25/2021 Analysts Set NeoGenomics, Inc. (NASDAQ:NEO) PT at $51.83 - Stock Observer NeoGenomics, Inc. (NASDAQ:NEO) has been assigned a consensus rating of ‚AuBuy‚Au from the twelve ratings firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a ... Au rating and a $55.00 price target on the stock. Needham & Company LLC restated a ‚Aubuy‚Au rating and issued a $55.00 price target on shares of NeoGenomics in a research report on Monday, August ...
8/23/2021 Analysts Expect NeoGenomics, Inc. (NASDAQ:NEO) to Post -$0.07 EPS Analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to report earnings per share of ($0.07) for the current fiscal quarter, according to Zacks Investment Research . Three analysts have provided estimates for NeoGenomics‚Ao earnings, with the highest ... equities research analysts have recently weighed in on the stock. Needham & Company LLC restated a ‚Aubuy‚Au rating and issued a $55.00 price objective on shares of NeoGenomics in a report on Monday, August 9th ...
8/23/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of ‚ÄúBuy‚Äù from Analysts Shares of NeoGenomics, Inc. (NASDAQ:NEO) have received an average rating of ‚AuBuy‚Au from the twelve ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the ... 51.83. NEO has been the subject of several research reports. Needham & Company LLC reaffirmed a ‚Aubuy‚Au rating and set a $55.00 price objective on shares of NeoGenomics in a report on Monday, August 9th ...
8/22/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings ... buy rating and a $55.00 price objective on the stock. Needham & Company LLC restated a buy rating and set a $55.00 price objective on shares of NeoGenomics in a research note on Monday, August 9th ...
8/21/2021 NeoGenomics (NASDAQ:NEO) Releases FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus ... has been the topic of a number of analyst reports. Needham & Company LLC restated a buy rating and set a $55.00 target price on shares of NeoGenomics in a research report on Monday, August 9th ...
8/21/2021 NeoGenomics (NASDAQ:NEO) Raised to ‚ÄúHold‚Äù at Zacks Investment Research Zacks Investment Research upgraded shares of NeoGenomics (NASDAQ:NEO) from a sell rating to a hold rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, ‚AuNeoGenomics, Inc. is a ... the stock in a research report on Monday, August 9th. Needham & Company LLC reaffirmed a buy rating and issued a $55.00 price objective on shares of NeoGenomics in a research report on Monday, August 9th ...
8/21/2021 NeoGenomics (NASDAQ:NEO) Raised to ‚ÄúHold‚Äù at Zacks Investment Research Zacks Investment Research upgraded shares of NeoGenomics (NASDAQ:NEO) from a sell rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, ‚AuNeoGenomics, Inc. is a high-complexity CLIA ... other research analysts have also recently commented on the stock. Needham & Company LLC reiterated a buy rating and set a $55.00 price target on shares of NeoGenomics in a research report on Monday, August 9th ...
8/21/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives $51.83 Consensus Price Target from Brokerages - Ticker Report Ticker Report NeoGenomics, Inc. (NASDAQ:NEO) has received an average recommendation of ‚AuBuy‚Au from the twelve ratings firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation ... Au rating and a $55.00 target price for the company. Needham & Company LLC reaffirmed a ‚Aubuy‚Au rating and issued a $55.00 target price on shares of NeoGenomics in a report on Monday, August 9th ...
8/21/2021 NeoGenomics (NASDAQ:NEO) Updates FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus earnings ... rating and a $55.00 price target on the stock. Finally, Needham & Company LLC reiterated a buy rating and issued a $55.00 price objective on shares of NeoGenomics in a report on Monday, August 9th. Two ...
8/20/2021 NeoGenomics (NASDAQ:NEO) Raised to ‚ÄúHold‚Äù at Zacks Investment Research Zacks Investment Research upgraded shares of NeoGenomics (NASDAQ:NEO) from a sell rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, ‚AuNeoGenomics, Inc. is a high-complexity ... company in a research note on Monday, August 9th. Finally, Needham & Company LLC reiterated a buy rating and issued a $55.00 price objective on shares of NeoGenomics in a research note on Monday, August 9th ...
8/20/2021 NeoGenomics, Inc. (NASDAQ:NEO) Expected to Post Quarterly Sales of $128.12 Million - Mayfield Recorder Mayfield Recorder Wall Street brokerages forecast that NeoGenomics, Inc. (NASDAQ:NEO) will post $128.12 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for NeoGenomics‚Ao earnings, with estimates ... A number of analysts have weighed in on the stock. Needham & Company LLC reissued a ‚Aubuy‚Au rating and issued a $55.00 price target on shares of NeoGenomics in a report on Monday, August 9th ...
8/20/2021 Zacks: Brokerages Anticipate NeoGenomics, Inc. (NASDAQ:NEO) Will Post Earnings of -$0.07 Per Share Equities research analysts expect NeoGenomics, Inc. (NASDAQ:NEO) to post ($0.07) earnings per share for the current quarter, Zacks reports. Three analysts have made estimates for NeoGenomics‚Ao earnings, with estimates ranging from ($0.09) to ... NeoGenomics. A number of research firms have commented on NEO. Needham & Company LLC reiterated a ‚Aubuy‚Au rating and issued a $55.00 price target on shares of NeoGenomics in a research note on Monday, August ...
8/19/2021 NeoGenomics (NASDAQ:NEO) Upgraded to ‚ÄúHold‚Äù at Zacks Investment Research NeoGenomics (NASDAQ:NEO) was upgraded by Zacks Investment Research from a ‚Ausell‚Au rating to a ‚Auhold‚Au rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, ‚AuNeoGenomics, Inc. is ... rating and a $55.00 target price for the company. Finally, Needham & Company LLC reaffirmed a ‚Aubuy‚Au rating and issued a $55.00 target price on shares of NeoGenomics in a research note on Monday, August ...
8/18/2021 NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of ‚ÄúBuy‚Äù by Brokerages American Banking News Shares of NeoGenomics, Inc. (NASDAQ:NEO) have earned an average rating of ‚AuBuy‚Au from the twelve analysts that are presently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with ... a ‚Auhold‚Au rating in a report on Tuesday. Finally, Needham & Company LLC restated a ‚Aubuy‚Au rating and set a $55.00 price objective on shares of NeoGenomics in a research note on Monday, August ...
8/18/2021 NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of ‚ÄúBuy‚Äù from Brokerages Mayfield Recorder Shares of NeoGenomics, Inc. (NASDAQ:NEO) have been given an average rating of ‚AuBuy‚Au by the twelve research firms that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the ... Au rating and a $55.00 target price for the company. Needham & Company LLC reissued a ‚Aubuy‚Au rating and set a $55.00 target price on shares of NeoGenomics in a research report on Monday, August ...
8/16/2021 NeoGenomics (NASDAQ:NEO) Releases FY 2021 Earnings Guidance NeoGenomics (NASDAQ:NEO) updated its FY 2021 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus estimate of $-0.210. The ... sell rating in a research report on Wednesday, April 28th. Needham & Company LLC restated a buy rating and set a $55.00 price objective on shares of NeoGenomics in a research report on Monday, August 9th ...
8/16/2021 NeoGenomics (NASDAQ:NEO) Releases FY 2021 Earnings Guidance Mayfield Recorder NeoGenomics (NASDAQ:NEO) issued an update on its FY 2021 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $-0.270-$-0.230 for the period, compared to the Thomson Reuters consensus ... sell rating in a research report on Wednesday, April 28th. Needham & Company LLC reiterated a buy rating and issued a $55.00 price target on shares of NeoGenomics in a research report on Monday, August 9th ...
8/15/2021 Zacks: Brokerages Expect NeoGenomics, Inc. (NASDAQ:NEO) to Announce -$0.07 Earnings Per Share Wall Street analysts forecast that NeoGenomics, Inc. (NASDAQ:NEO) will report ($0.07) earnings per share (EPS) for the current quarter, Zacks reports. Three analysts have made estimates for NeoGenomics‚Ao earnings. The lowest EPS estimate ... for the company in a report on Monday, August 9th. Needham & Company LLC reaffirmed a ‚Aubuy‚Au rating and set a $55.00 price target on shares of NeoGenomics in a report on Monday, August 9th ...